Rare diseases in EU
Why do rare diseases need specific EU support? More ...
Euro Histio Net has received funding from the European Union, in the framework of the Public Health Programme. More ...
» Expert Histio Net » Literature  · 


Autor(en) Titel Quelle Links
Cantu MA, Lupo PJ, Bilgi M, Hicks MJ, Allen CE, McClain KL Optimal therapy for adults with Langerhans cell histiocytosis bone lesions. [+] PloS one 2012, 7:e43257  
Canuet M, Kessler R, Jeung MY, Métivier AC, Chaouat A, Weitzenblum E Correlation between high-resolution computed tomography findings and lung function in pulmonary Langerhans cell histiocytosis. [+] Respiration; international review of thoracic diseases 2007, 74: 640  
Caputo, R Text Atlas of Histiocytic Syndromes : A Dermatological Perspective. Informa Healthcare 1998  
Cassady JR Current role of radiation therapy in the management of histiocytosis-X. [+] Hematology/oncology clinics of North America 1987, 1: 123  
Chikwava K, Jaffe R Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders. [+] Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2004 Nov-Dec; 7: 607  
Chohan G, Barnett Y, Gibson J, Reddel SW, Barnett MH Langerhans cell histiocytosis with refractory central nervous system involvement responsive to infliximab. Journal of neurology, neurosurgery, and psychiatry 2012, 83: 573  
Chu A Dermatological Aspects and Presentation of an Adult Clinic . Oral Presentation at the Annual Meeting of the Histiocyte Society Vienna 2011  
Colombat M, Stern M, Groussard O, Droz D, Brauner M, Valeyre D, Mal H, Taillé C, Monnet I, Fournier M, Herson S, Danel C Pulmonary cystic disorder related to light chain deposition disease. [+] American journal of respiratory and critical care medicine 2006 Apr 1; 173: 777  
8 items found

The literature database is sorted by the first letter of the author's last name - please choose from the alphabet. It comprises the references that were reported by the trial co-ordinating centres and those which are referenced in this information service, for example by the patient information texts.